Jan 31, 2023 · Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive, and entrepreneur, appointed Chief Executive Officer at Hinge Bio. “The opportunity to create novel technologies that can be translated into therapeutics that improve patients’ lives has motivated my entire career,” said Dr. Selick.

Harold E. “Barry” Selick, Ph.D., joined Hinge Bio as CEO in January 2023. He was most recently the Vice-Chancellor of Business Development, Innovation, and Partnerships at the University of California, San Francisco, a position that he had held since April 2017.

Jan 5, 2023 · I am writing to let you know that Barry Selick, PhD, who has served as vice chancellor for business development, innovation and partnerships at UCSF since 2017, will step down from his post on January 8.

Jan 18, 2023 · Harold E. “Barry” Selick, Ph.D., a successful and distinguished biopharmaceutical scientist, senior executive and venture investor, was named as Chief Executive Officer. Carin Rollins, a Company...

Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive, and entrepreneur, appointed Chief Executive Officer at Hinge Bio. “The opportunity to create...

Apr 25, 2017 · Harold E. “Barry” Selick, PhD – UCSF’s new vice chancellor for business development, innovation and partnerships – has deep biotech industry knowledge and longstanding ties to the University.

View the profiles of people named Barry Sellick. Join Facebook to connect with Barry Sellick and others you may know. Facebook gives people the power to...

Jan 15, 2025 · Barry Sellick died in a collision on the A38 Wellington New Road just before 1am on Monday 13 January. Avon and Somerset Police say a specialist family liaison officer is supporting the 68-year ...

Barry Sellick is on Facebook. Join Facebook to connect with Barry Sellick and others you may know. Facebook gives people the power to share and makes the world more open and connected.

This site is a tribute to Barry Sellick. He is much loved and will always be remembered.